Figure 4 | British Journal of Cancer

Figure 4

From: Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR

Figure 4

Normal tissue biodistribution of radiolabelled ch806 over 7 days in BALB/c nude mice bearing tumour xenografts (n=5). Results of the biodistribution of (A) 111In-CHX-A″-DTPA-ch806 and (B) 125I-ch806 are presented for each tissue expressed as mean (bars;±s.d.) percent injected dose per gram (%ID g−1) values.

Back to article page